India

Delhi High Court Dismisses Plea for Mandatory Disclosure of Drug Side Effects by Doctors

The Delhi High Court has dismissed a plea seeking a directive requiring medical professionals to explicitly state all potential risks and side effects of medicines or pharmaceutical drugs when administered to a patient. The division bench, consisting of Acting Chief Justice Manmohan Singh and Justice Manmeet Pritam Singh Arora, referred to the Drugs and Cosmetics Act of 1945, which mandates drug manufacturers or their agents to provide package inserts detailing the side effects to consumers and pharmacies.

The bench stated that since the legislature has assigned this responsibility to manufacturers and pharmacists, the court cannot issue the directions sought in the Public Interest Litigation (PIL) as it would be tantamount to judicial overreach.

PIL Rejected

The bench highlighted that the petitioner did not dispute the adequacy of the information provided by manufacturers through inserts accompanying medicines sold by registered pharmacists. However, the petitioner contended that if doctors included this information alongside their prescriptions, patients and caregivers could make informed choices with valid consent. The court noted that the legislature had intentionally placed this duty on manufacturers and pharmacists, leaving no grounds for the court to issue the directions requested in the PIL. Since the PIL acknowledged that there was no regulatory gap, the court concluded that the requested directions could not be granted. Consequently, the PIL and associated applications were dismissed.

Also read: Lok Sabha Elections Phase 5: 56.68% Voter Turnout by 5 PM, West Bengal Tops with 73%

Petitioner’s Argument

The PIL was filed by Jacob Vadakanchery, who argued that medicines can have severe side effects and that patients have a right to make informed choices. He asserted that it should be mandatory for prescribing doctors to inform patients about these side effects. Vadakanchery claimed that prescribing medicine without detailing potential side effects does not constitute obtaining valid consent from the patient. He urged for the responsibility to shift from manufacturers and pharmacists to medical practitioners to ensure patients are properly informed.

Kavya Bhatt

Recent Posts

PM Modi Pays Tribute To Cultural Icons In ‘Mann Ki Baat’

PM Modi pays tribute to Bhupen Hazarika, Zubeen Garg, and SL Bhyrappa in ‘Mann Ki…

34 mins ago

India Poised To Lead Global Green Hydrogen Revolution

India is accelerating its green hydrogen ambitions under the National Green Hydrogen Mission, with S&P…

1 hour ago

India Charts New Course In Dispute Resolution At 2nd National Mediation Conference

India’s 2nd National Mediation Conference in Bhubaneswar underscores mediation’s growing role under the Mediation Act…

1 hour ago

PM Modi Calls For Atmanirbhar Resolve Through Swadeshi Shopping

Prime Minister Narendra Modi called on citizens to embrace Swadeshi and take a pledge to…

4 hours ago

PM Modi Hails RSS’s Century Of Service, Says ‘Nation First’ Always Paramount

PM Modi hailed the RSS’s century-long journey, praising its patriotism, service, and ‘nation first’ principle.

5 hours ago

PM Modi Announces Rs 2 Lakh Ex-Gratia For Karur Stampede Victims

Prime Minister Modi announced financial assistance of Rs 2 lakh for the families of Karur…

5 hours ago